JESSA HOLLINGSWORTH: Open Payments
NPI 1538677927 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,586 in 105 payments from 16 companies in 2025. Trend: 2023 $1,794 · 2024 $1,984 · 2025 $2,586
Food & beverage: $2,474Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $738 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $318 |
| ABBVIE INC. | 7 | $277 |
| E.R. Squibb & Sons, L.L.C. | 6 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $234 |
| Neurocrine BioSciences, Inc. | 5 | $148 |
| Axsome Therapeutics, Inc. | 7 | $146 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Lundbeck LLC | 3 | $62 |
| ACADIA Pharmaceuticals Inc | 2 | $62 |
Products named: AUSTEDO XR, CAPLYTA, UZEDY, VRAYLAR, COBENFY, TRINTELLIX, REXULTI, INGREZZA.
Industry payments across SC — which companies pay providers there.
